Archive
CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: Advances from functional genomics and pharmacoepidemiology
Contributors: Colbourne, Lucy; Harrison, Paul J; Mould, Arne; Tunbridge, Elizabeth
Subjects: Genetics, Neuropsychiatry
New drug targets in psychiatry: Neurobiological considerations in the genomics era
Contributors: Harrison, Paul J; Mould, Arne; Tunbridge, Elizabeth
Subjects: Psychosis, Schizophrenia
Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia
Contributors: Al-Juffali, Noura; Mould, Arne; Tunbridge, Elizabeth
Subjects: Cognition, Schizophrenia
The Oxford study of Calcium channel Antagonism, Cognition, Mood instability and Sleep (OxCaMS): study protocol for a randomised controlled, experimental medicine study
Contributors: Atkinson, Lauren Z; Cipriani, Andrea; Colbourne, Lucy; Harmer, Catherine J; Hinds, Christopher; Jones, Helen; Mould, Arne; Nobre, Anna C; Rendell, Jennifer; Smith, Alexander L W; Tunbridge, Elizabeth
Subjects: Bipolar Disorder, Depressive Disorders, Memory, Mood Instability, Sleep